A design for phase II testing of anticancer agents within a phase III clinical trial
- 30 June 1988
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 9 (2) , 107-118
- https://doi.org/10.1016/0197-2456(88)90032-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.Journal of Clinical Oncology, 1987
- Calibrated phase II clinical trials in oncologyStatistics in Medicine, 1986
- Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureAmerican Journal of Clinical Oncology, 1985
- Consideration of covariates and stratification in sample size determination for survival time studiesJournal of Chronic Diseases, 1985
- The asymptotic properties of nonparametric tests for comparing survival distributionsBiometrika, 1981
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972